Cargando…

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal history of invasive breast cancer is unknown. We identified a cohort of 148 female BRCA1 or BRCA2 mutation carriers (115 and 33, respectively) who previously were treated for un...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Sprundel, T C, Schmidt, M K, Rookus, M A, Brohet, R, van Asperen, C J, Rutgers, E J Th, van‘t Veer, L J, Tollenaar, R A E M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361560/ https://www.ncbi.nlm.nih.gov/pubmed/16052221 http://dx.doi.org/10.1038/sj.bjc.6602703

Ejemplares similares

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
por: Schmidt, MK, et al.
Publicado: (2005)

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up
por: Olivier, R I, et al.
Publicado: (2004)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
por: Metcalfe, Kelly, et al.
Publicado: (2014)

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
por: Scheepens, Josien C.C., et al.
Publicado: (2021)

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
por: Akdeniz, Delal, et al.
Publicado: (2021)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients
por: Falco, Giuseppe, et al.
Publicado: (2016)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019)

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015)

Contralateral prophylactic mastectomy: current perspectives
por: Yao, Katharine, et al.
Publicado: (2016)

Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences
por: Makhnoon, Sukh, et al.
Publicado: (2022)

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
por: Davies, Kalatu R, et al.
Publicado: (2015)

Abstract: Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies and Reconstruction
por: Schultz, Benjamin D., et al.
Publicado: (2018)

Low-dose ionizing radiation significantly increases the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study (IBCCS)
por: Van Leeuwen, FE, et al.
Publicado: (2005)

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study
por: Wevers, M. R., et al.
Publicado: (2015)

Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status
por: Baptiste, Dadrie F., et al.
Publicado: (2017)

Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer
por: Wahlen, Madison M., et al.
Publicado: (2023)

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis
por: van den Broek, Alexandra J., et al.
Publicado: (2015)

The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
por: Grossman, Sharon Galper
Publicado: (2015)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy
por: Agarwal, Shailesh, et al.
Publicado: (2020)

Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)
por: Rookus, MA, et al.
Publicado: (2005)

Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status
por: Jeon, Ho Jong, et al.
Publicado: (2019)

Patient opinions on contralateral prophylactic mastectomy: A patient-driven discussion in need of tuning?
por: Brown, Zachary M., et al.
Publicado: (2022)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
por: Singareeka Raghavendra, Akshara, et al.
Publicado: (2021)

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
por: Verhoog, L C, et al.
Publicado: (2000)

Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy
por: Venetis, Maria K., et al.
Publicado: (2018)

Abstract 71: Postoperative Quality of Life in Patients Undergoing Contralateral Prophylactic Mastectomy with Breast Reconstruction
por: Rizzo, Amanda M., et al.
Publicado: (2018)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
por: Drooger, Jan C., et al.
Publicado: (2015)

The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
por: Ochaney, Priyanka, et al.
Publicado: (2019)

Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
por: Sciarra, Antonella, et al.
Publicado: (2021)

Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy
por: Pender, Kelly, et al.
Publicado: (2023)

Factors associated with contralateral preventive mastectomy
por: Yakoub, Danny, et al.
Publicado: (2015)

Immediate Implant-Based Reconstruction of the Contralateral or Bilateral Prophylactic Mastectomies: Risk Factor Analysis for Index and Prophylactic Breast
por: Dolen, Utku Can, et al.
Publicado: (2020)

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment
por: van Dijk, S, et al.
Publicado: (2003)

Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
por: van Barele, Mark, et al.
Publicado: (2023)

Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer
por: Kim, Younji, et al.
Publicado: (2017)

Trends in utilization of contralateral prophylactic mastectomy among different age, racial and ethnic groups
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fpvv62inu01cjslgt8thqpocgp